Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies

View through CrossRef
This review supplies the reader with a detailed overview on the utilization of intramolecular processes for a design and synthesis of prodrugs. It is well known that a respected number of drugs suffer from low bioavailability, toxicity, unpleasant taste and presystemic first-pass metabolism which result in drug inactivation. The classical prodrug approach in which the linkage attaching the parent drug to its non-toxic linker and cleaved by in vivo enzyme’s catalyzed reactions has proven its success in solving toxicity and bioavailability related issues. On the other hand, prodrugs based on chemical interconversion in which the prodrug releases the corresponding active parent drug via inter or intramolecular chemical process in the absence of an enzyme is considered as a better alternative approach since the prodrug cleavage is not dependent in the efficiency or quantity of the enzyme catalyzes the interconversion of the prodrug. Examples of successful prodrugs using the chemical approach via intramolecular processes such as cyclization reactions are illustrated as well. </p> <p> In addition, another part of this review is devoted to cover reported studies on enzyme models and their utilization for the design and synthesis of a variety of novel prodrugs. In this approach, computational calculations using DFT and MM methods were exploited and correlations between experimentally determined and computed values of the rate-limiting step in the studied intramolecular processes were utilized in the prodrugs design. Selected examples of the designed prodrugs include aza-nucleosides for the treatment of myelodysplastic syndromes, the anti-Parkinson’s agent dopamine, the anti-viral acyclovir, the anti-malarial atovaquone, and statins for lowering cholesterol levels in the blood, the antihypertensive atenolol, the antibacterial cefuroxime, the anti-bleeding tranexamic acid, the decongestant phenylephrine, and the pain killer paracetamol.
Title: Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Description:
This review supplies the reader with a detailed overview on the utilization of intramolecular processes for a design and synthesis of prodrugs.
It is well known that a respected number of drugs suffer from low bioavailability, toxicity, unpleasant taste and presystemic first-pass metabolism which result in drug inactivation.
The classical prodrug approach in which the linkage attaching the parent drug to its non-toxic linker and cleaved by in vivo enzyme’s catalyzed reactions has proven its success in solving toxicity and bioavailability related issues.
On the other hand, prodrugs based on chemical interconversion in which the prodrug releases the corresponding active parent drug via inter or intramolecular chemical process in the absence of an enzyme is considered as a better alternative approach since the prodrug cleavage is not dependent in the efficiency or quantity of the enzyme catalyzes the interconversion of the prodrug.
Examples of successful prodrugs using the chemical approach via intramolecular processes such as cyclization reactions are illustrated as well.
</p> <p> In addition, another part of this review is devoted to cover reported studies on enzyme models and their utilization for the design and synthesis of a variety of novel prodrugs.
In this approach, computational calculations using DFT and MM methods were exploited and correlations between experimentally determined and computed values of the rate-limiting step in the studied intramolecular processes were utilized in the prodrugs design.
Selected examples of the designed prodrugs include aza-nucleosides for the treatment of myelodysplastic syndromes, the anti-Parkinson’s agent dopamine, the anti-viral acyclovir, the anti-malarial atovaquone, and statins for lowering cholesterol levels in the blood, the antihypertensive atenolol, the antibacterial cefuroxime, the anti-bleeding tranexamic acid, the decongestant phenylephrine, and the pain killer paracetamol.

Related Results

Recent Advances in Prodrug Approach over Conventional Drug Therapy
Recent Advances in Prodrug Approach over Conventional Drug Therapy
Background: Prodrugs represent a strategically designed category of medicinal compounds aimed at optimizing drug pharmacokinetics. By modifying the pharmacological action of the dr...
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Background: The design and development of prodrugs is the most common and effective strategy to overcome pharmacokinetic and pharmacodynamic drawbacks of active drugs. A respected ...
Cash‐based approaches in humanitarian emergencies: a systematic review
Cash‐based approaches in humanitarian emergencies: a systematic review
This Campbell systematic review examines the effectiveness, efficiency and implementation of cash transfers in humanitarian settings. The review summarises evidence from five studi...
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
AbstractThe clinical approval of platinum‐based drugs has prompted the development of novel metallo‐complexes during the last several decades, while severe problems, especially for...
Peroxynitrite‐Promoted Persulfide Prodrugs with Protective Potential against Paracetamol Poisoning
Peroxynitrite‐Promoted Persulfide Prodrugs with Protective Potential against Paracetamol Poisoning
AbstractThe newly emerging persulfide prodrugs provide additional options for the profound study of persulfide, a fascinating molecule expected to intervene in biological functions...
Use of prodrugs in cancer therapy - A Review
Use of prodrugs in cancer therapy - A Review
A prodrug is a medicine that is primarily used after administration, that is metabolized into a pharmacologically active drug. A prodrug is generally a precursor form of a drug. A ...
Provide of brief overview of the pharmaceuticalindustry, focusing on Generic Drugs and Prodrugs
Provide of brief overview of the pharmaceuticalindustry, focusing on Generic Drugs and Prodrugs
The pharmaceutical industry is a cornerstone of modern healthcare, driving the discovery, development, and distribution of medications that treat, prevent, and manage diseases. Wit...

Back to Top